Shares of Novo Nordisk A/S (NVO) climbed 0.4% on Monday and rose in extended trading after the Danish drugmaker said it had ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Pharmacies told to stop making custom versions of Wegovy and Zepbound after shortages declared officially over ...

Novo Nordisk (NVO) asked the Food and Drug Administration to approve a pill version of its popular weight loss drug in obesity earlier this ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

Obesity alters how medications work, increasing the risk of underdosing, overdosing, and unknown interactions. Are package ...

Federal health officials suggest the additives are contributing to rising rates of diabetes, obesity and ADHD in children.

Food companies have voluntarily consented to getting rid of the artificial dyes, Makary said, but there is currently no ...

U.S. FDA Commissioner Marty Makary said on Tuesday that the agency plans to remove petroleum-based synthetic food dyes from ...

The FDA and HHS will phase out eight synthetic food dyes by 2026, citing health risks such as ADHD and obesity. The move ...

The FDA announced it would phase out all petroleum-based synthetic dyes from the United States' food supply and medications.